Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


INTERACTION OF THE CHEMOTHERAPY SIDE-PRODUCT CHLOROACETALDEHYDE WITH HUMAN ORGANIC ANION TRANSPORTER, HOAT1
Abstract number: PW05A-17

Schwerdt1 G, Kirchhoff1 A, Wollny1 B, Sauvant1 C, Gekle1 M

1Physiologisches Institut, Universitt Wrzburg

Kidney damage with Fanconi syndrome can occur frequently as side effect of chemotherapy using ifosfamide or cyclophosphamide. It is supposed that one metabolite of both, chloroacetaldehyde (CAA), is in part responsible for the observed damages of the proximal tubule. Nothing is known about transport of CAA into proximal tubule cells. Therefore, we studied the interaction of CAA with hOAT1 using Chinese hamster ovary (CHO) cells stably transfected with hOAT1 and compared it with mock-transfected CHO cells serving as control. Fluorescein net uptake (measured after 1 min. incubation) was higher in OAT1-transfected cells compared to control cells. Fluorescein net uptake was slightly and significantly increased by 1000-fold excess of CAA whereas in control cells net uptake was clearly increased. Higher CAA concentrations partially inhibited fluorescein uptake in OAT1-transfected cells but still increased net uptake in control cells. In both cell types, CAA still increased net uptake of fluorescein in the presence of probenecid. We conclude that CAA may interact with OAT1 but that CAA interacts also by inhibition of as yet unknown export mechanisms leading to increased intracellular fluorescein content. This hypothesis seems to be confirmed by efflux measurements.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :PW05A-17

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE